Abstract
We conducted a weight-of-evidence (WoE) analysis to assess whether the current body of research supports a causal relationship between long-term ozone exposure (defined by EPA as at least 30 days in duration) at ambient levels and cardiovascular (CV) effects. We used a novel WoE framework based on the United States Environmental Protection Agency's National Ambient Air Quality Standards causal framework for this analysis. Specifically, we critically evaluated and integrated the relevant epidemiology and experimental animal data and classified a causal determination based on categories proposed by the Institute of Medicine's 2008 report, Improving the Presumptive Disability Decision-making Process for Veterans. We found that the risks of CV effects are largely null across human and experimental animal studies. The few positive associations reported in studies of CV morbidity and mortality are very small in magnitude, mainly reported in single-pollutant models, and likely attributable to bias, chance, or confounding. The few positive effects in experimental animal studies were observed mainly in ex vivo studies at high exposures, and even the in vivo findings are not likely relevant to humans. The available data also do not support a biologically plausible mechanism for the effects of ozone on the CV system. Overall, the current WoE provides no convincing case for a causal relationship between long-term exposure to ambient ozone and adverse effects on the CV system in humans, but the limitations of the available studies preclude definitive conclusions regarding a lack of causation; thus, we categorize the strength of evidence for a causal relationship between long-term exposure to ozone and CV effects as “below equipoise.”
Declaration of interest
The authors are employed by Gradient, a private environmental consulting firm, and Albany Medical College, a private medical school. The Gradient staff have strong expertise in assessing human, experimental animal, and mechanistic data in WoE analyses (as is evident in recent evaluations conducted for bisphenol A, naphthalene, formaldehyde, chlorpyrifos, methanol, styrene, nickel, and toluene diisocyanate) and have presented several of these analyses to regulatory bodies. In addition, Gradient staff, including the authors of this paper, have carefully evaluated the science underlying EPA's review of various NAAQS and offered both oral and written testimony to EPA. Gradient has also addressed issues on systematic review and integration of evidence for a number of clients. The authors conducted the work reported in this paper during the normal course of employment, with financial support provided by the Texas Commission on Environmental Quality (TCEQ). The authors have the sole responsibility for the writing, content, and conclusions in this paper. The conclusions are not necessarily those of the TCEQ.